{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:48:34Z","timestamp":1794408514916,"version":"4.9.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We aimed to develop tools that could predict the occurrence of distant metastases in melanoma and its prognosis based on clinical and pathological characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We obtained data from the Surveillance, Epidemiology, and End Results (SEER) database of melanoma patients diagnosed between 2010 and 2019. Logistic analyses were performed to identify independent risk factors associated with distant metastasis. Additionally, multivariate Cox analyses were conducted to determine independent prognostic factors for patients with distant metastasis. Two nomograms were established and evaluated with the receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA). Furthermore, we performed a retrospective analysis of melanoma with distant metastasis from our institute between March 2018 and June 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the total 19\u2005396 melanoma patients, 352 (1.8%) had distant metastases at the time of diagnosis. The following clinical and pathological characteristics were identified as independent risk factors for distant metastasis in melanoma: N stage, tumor size, ulceration, mitosis, primary tumor site, and pathological subtype. Furthermore, tumor size, pathological subtype, and radiotherapy were identified as independent prognostic factors. The results of the training and validation cohorts\u2019 ROC curves, calibration, DCA, and Kaplan\u2013Meier survival curves demonstrate the effectiveness of the two nomograms. The retrospective study results from our center supported the results from the SEER database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The clinical and pathological characteristics of melanoma can predict a patient\u2019s risk of metastasis and prognosis, and the two nomograms are expected to be effective tools to guide therapy decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000000871","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T06:01:49Z","timestamp":1705903309000},"page":"461-474","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic and prognostic risk factors analysis for distant metastasis in melanoma: a population-based study"],"prefix":"10.1097","volume":"33","author":[{"given":"Junwei","family":"Sun","sequence":"first","affiliation":[{"name":"Peking University China-Japan Friendship School of Clinical Medicine, Beijing"},{"name":"Department of Neurosurgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhisheng","family":"Kan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4065\/72.4.356","article-title":"Malignant melanoma: prognostic indicators.","volume":"72","author":"Ahmed","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ad.2011.06.002","article-title":"Factores de riesgo de met\u00e1stasis en tr\u00e1nsito en pacientes con melanoma cut\u00e1neo.","volume":"103","author":"Almiron","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology \u2013 more than meets the eye.","volume":"16","author":"Balachandran","year":"2009","journal-title":"Lancet Oncol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","article-title":"An evidence-based staging system for cutaneous melanoma.","volume":"54","author":"Balch","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification.","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijrobp.2005.06.030","article-title":"Combined-modality therapy for patients with regional nodal metastases from melanoma.","volume":"64","author":"Ballo","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/COC.0b013e3181f9456a","article-title":"Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.","volume":"34","author":"Bedikian","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"R8-20250527","first-page":"427","article-title":"Acral lentiginous melanoma.","volume":"145","author":"Bradford","year":"2008","journal-title":"Arch Dermatol"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"e14193","DOI":"10.1111\/dth.14193","article-title":"Diagnosis and treatment of melanoma bone metastasis: a multidisciplinary approach.","volume":"33","author":"Caldaria","year":"2020","journal-title":"Dermatol Ther"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.138.5.609","article-title":"Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.","volume":"138","author":"Chamberlain","year":"2002","journal-title":"Arch Dermatol"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.3390\/cancers15153989","article-title":"Topographical and chronological analysis of thin cutaneous melanoma\u2019s progressions: a multicentric study.","volume":"15","author":"Chousakos","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","article-title":"A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.","volume":"15","author":"Clark","year":"1984","journal-title":"Hum Pathol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"366","DOI":"10.6004\/jnccn.2012.0036","article-title":"Melanoma.","volume":"10","author":"Coit","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cancers3010126","article-title":"Decoding melanoma metastasis.","volume":"3","author":"Damsky","year":"2010","journal-title":"Cancers (Basel)"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/onc.2013.194","article-title":"Melanoma metastasis: new concepts and evolving paradigms.","volume":"33","author":"Damsky","year":"2013","journal-title":"Oncogene"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jaad.2019.01.081","article-title":"Early detection of acral melanoma: a review of clinical, dermoscopic, histopathologic, and molecular characteristics.","volume":"81","author":"Darmawan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2133.2007.07937.x","article-title":"Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.","volume":"157","author":"Debarbieux","year":"2007","journal-title":"Br J Dermatol"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/jnci\/djz034","article-title":"Distinct clinicopathological and prognostic features of thin nodular primary melanomas: an international study from 17 centers.","volume":"111","author":"Dessinioti","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.surg.2012.07.006","article-title":"Outcomes and prognostic factors in nodular melanomas.","volume":"152","author":"Egger","year":"2012","journal-title":"Surgery"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41419-022-04718-8","article-title":"SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma.","volume":"13","author":"Fan","year":"2022","journal-title":"Cell Death Dis"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1200\/JCO.2004.12.015","article-title":"Thin Primary cutaneous malignant melanoma: a prognostic tree for 10-ye ar metastasis is more accurate than American Joint Committee on Cancer staging.","volume":"22","author":"Gimotty","year":"2004","journal-title":"J Clin Oncol"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archdermatol.2008.537","article-title":"Estrogen receptor expression in cutaneous melanoma.","volume":"145","author":"Giorgi","year":"2009","journal-title":"Arch Dermatol"},{"key":"R26-20250527","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/CMR.0b013e3283577b96","article-title":"The prognostic impact of the anatomical sites in the \u2018head and neck melanoma\u2019.","volume":"22","author":"Giorgi","year":"2012","journal-title":"Melanoma Res"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archotol.133.5.442","article-title":"Epidemiological features and prognostic factors of cutaneous head and neck melanoma.","volume":"133","author":"Golger","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/fon.14.300","article-title":"Radiotherapy for cutaneous melanoma: current and future applications.","volume":"11","author":"Gorayski","year":"2015","journal-title":"Future Oncol"},{"key":"R29-20250527","doi-asserted-by":"crossref","first-page":"985051","DOI":"10.3389\/fimmu.2022.985051","article-title":"Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/bjc.1992.373","article-title":"The prognosis of primary and metastasizing melanoma An evaluation of the TNM classification in 2,495 patients.","volume":"66","author":"H\u00e4ffner","year":"1992","journal-title":"Br J Cancer"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1200\/JCO.2016.71.9393","article-title":"Conditional survival: an assessment of the prognosis of patients at time points after initial diagnosis and treatment of locoregional melanoma metastasis.","volume":"35","author":"Haydu","year":"2017","journal-title":"J Clin Oncol"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.2006.07455.x","article-title":"Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.","volume":"155","author":"Hoersch","year":"2006","journal-title":"Br J Dermatol"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1245\/s10434-014-3829-9","article-title":"Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.","volume":"21","author":"Huismans","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/SLA.0b013e31824c4b0b","article-title":"Prognostic importance of the extent of ulceration in patients with clinically localized cutaneous melanoma.","volume":"255","author":"In 't Hout","year":"2012","journal-title":"Ann Surg"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1755-148X.2010.00694.x","article-title":"Reactive oxygen species and melanoma: an explanation for gender differences in survival?","volume":"23","author":"Joosse","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2011.38.0584","article-title":"Superior outcome of women with stage I\/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer Phase III Trials.","volume":"30","author":"Joosse","year":"2012","journal-title":"J Clin Oncol"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2006.02.034","article-title":"Tumor size improves the accuracy of tnm predictions in patients with renal cancer.","volume":"50","author":"Karakiewicz","year":"2006","journal-title":"Eur Urol"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/ijc.25747","article-title":"Age as a key factor influencing metastasizing patterns and disease-specific survival after sentinel lymph node biopsy for cutaneous melanoma.","volume":"129","author":"Kretschmer","year":"2011","journal-title":"Int J Cancer"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archderm.144.4.515","article-title":"Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.","volume":"144","author":"Lachiewicz","year":"2008","journal-title":"Arch Dermatol"},{"key":"R40-20250527","doi-asserted-by":"crossref","first-page":"21012","DOI":"10.1038\/s41598-021-00386-4","article-title":"Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaad.2012.09.047","article-title":"Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia.","volume":"68","author":"Mar","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/1097-0142(197312)32:6<1446::AID-CNCR2820320623>3.0.CO;2-8","article-title":"The classification of malignant melanoma and its histologic reporting.","volume":"32","author":"McGovern","year":"1973","journal-title":"Cancer"},{"issue":"Suppl 2","key":"R43-20250527","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1054\/bjoc.2001.1771","article-title":"Cutaneous melanoma.","volume":"84","author":"N\u00e9grier","year":"2001","journal-title":"Br J Cancer"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/ijc.29281","article-title":"Risk factors related to late metastases in 1,372 melanoma patients disease-free more than 10 years.","volume":"136","author":"Osella-Abate","year":"2014","journal-title":"Int J Cancer"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.amjsurg.2010.07.037","article-title":"Does mitotic rate predict sentinel lymph node metastasis or survival in patients with intermediate and thick melanoma?","volume":"200","author":"Roach","year":"2010","journal-title":"Am J Surg"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","article-title":"Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.","volume":"88","author":"Sampson","year":"1998","journal-title":"J Neurosurg"},{"key":"R47-20250527","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaad.2004.01.030","article-title":"Cutaneous melanoma\u2014Past, present, and future.","volume":"51","author":"Schaffer","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R48-20250527","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archdermatol.2011.264","article-title":"The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.","volume":"148","author":"Shaikh","year":"2012","journal-title":"Arch Dermatol"},{"key":"R49-20250527","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamadermatol.2014.635","article-title":"Characteristics and associations of high-mitotic-rate melanoma.","volume":"150","author":"Shen","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R50-20250527","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamadermatol.2017.2497","article-title":"Association between patient age and lymph node positivity in thin melanoma.","volume":"153","author":"Sinnamon","year":"2017","journal-title":"JAMA Dermatol"},{"key":"R51-20250527","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0.CO;2-X","article-title":"TNM classification of malignant tumors a comparison between the new (1987) and the old editions.","volume":"61","author":"Sobin","year":"1988","journal-title":"Cancer"},{"key":"R52-20250527","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1245\/ASO.2004.03.044","article-title":"Mitotic Rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.","volume":"11","author":"Sondak","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"R53-20250527","doi-asserted-by":"crossref","first-page":"515606","DOI":"10.3389\/fonc.2020.515606","article-title":"Dual primary cancer patients with lung cancer as a second primary malignancy: a population-based study.","volume":"10","author":"Song","year":"2020","journal-title":"Front Oncol"},{"key":"R54-20250527","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ijd.15939","article-title":"Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma.","volume":"61","author":"Ta\u015f","year":"2021","journal-title":"Int J Dermatol"},{"key":"R55-20250527","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1186\/1476-069X-11-S1-S12","article-title":"Associations between environmental factors and incidence of cutaneous melanoma. Review.","volume":"11","author":"Volkovova","year":"2012","journal-title":"Environ Health"},{"key":"R56-20250527","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/cncr.23955","article-title":"Changes in the presentation of nodular and superficial spreading melanomas over 35 years.","volume":"113","author":"Warycha","year":"2008","journal-title":"Cancer"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000000871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:36:21Z","timestamp":1786034181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000871","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}